Section 4-41a-702 - Reporting - Inspections - Seizure by the department(1) If an independent cannabis testing laboratory determines that the results of a lab test indicate that a cannabis or cannabis product batch may be unsafe for human use: (a) the independent cannabis testing laboratory shall report the results and the cannabis or cannabis product batch to: (ii) the cannabis production establishment that prepared the cannabis or cannabis product batch;(b) the department shall place a hold on the cannabis or cannabis product batch to: (i) investigate the cause of the defective batch; and(ii) make a determination; and(c) the cannabis production establishment that prepared the cannabis or cannabis product batch may appeal the determination described in Subsection (1)(b)(ii) to the department.(2) If the department determines, under Subsection (1)(b)(ii) or following an appeal under Subsection (1)(c), that a cannabis or cannabis product prepared by a cannabis production establishment is unsafe for human consumption, the department may seize, embargo, or destroy, in the same manner as a cannabis production establishment under Section 4-41a-405, the cannabis or cannabis product batch.(3) If an independent cannabis testing laboratory determines that the results of a lab test indicate that the cannabinoid content of a cannabis or cannabis product batch diverges more than 10% from the amounts the label indicates, the cannabis processing facility may not sell the cannabis or cannabis product batch unless the facility replaces the incorrect label with a label that correctly indicates the cannabinoid content.Amended by Chapter 350, 2021 General Session ,§ 12, eff. 3/17/2021.Renumbered from § 4-41b-702 and amended by Chapter 1, 2018SP3 General Session ,§ 27, eff. 12/3/2018.Added by Utah Proposition 2, Medical Marijuana Initiative (2018), approved by the voters at the general election held on 11/6/2018, and effective 12/1/2018.